Biologically plausible learning mechanisms have implications for understanding brain functions and engineering intelligent systems. Inspired by the multi-scale recurrent connectivity in the brain, we ...

Deep within the source code of this online multiplayer game lies an enigmatic number that puzzles and inspires experts to this day ...

The Indian Medical Council has launched a new pathogen detection tool. An AI-driven tool could predict the spread of serious diseases, and here is what you should know.

Supervised learning algorithms like Random Forests, XGBoost, and LSTMs dominate crypto trading by predicting price directions or values from labeled historical data, enabling precise signals such as ...

Jan 10 (Reuters) - Elon Musk said on Saturday that social media platform X will open to the public its new algorithm, including all code for organic and advertising post recommendations, in seven days ...

While the creation of this new entity marks a big step toward avoiding a U.S. ban, as well as easing trade and tech-related tensions between Washington and Beijing, there is still uncertainty ...

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring ...

Instagram is introducing a new tool that lets you see and control your algorithm, starting with Reels, the company announced on Wednesday. The new tool, called “Your Algorithm,” lets you view the ...

RNA interference using small interfering RNAs (siRNAs) has become a mainstay of functional gene characterization and has generated over a dozen FDA-approved therapeutics and drugs in late-stage ...

Please provide your email address to receive an email when new articles are posted on . ACOG recommends concurrent sexual partner therapy with antimicrobial agents for some patients with recurrent ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...